<unk>  is a non-steroidal anti-inflammatory agents that is FDA approved for the treatment of patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age.   Common adverse reactions include gastrointestinal perforation and necrotizing enterocolitis.
Ibuprofen lysine
Ketoprofen
Aceclofenac
Naproxen sodium
Dexketoprofen
Acetaminophen 
Diclofenac 
Fenoprofen